Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE)

Vaccine

Volumn 31, Issue 41, 2013, Pages 4523-4527

  Escribano Romero, E ^a   Gamino, V ^b   Merino Ramos, T ^a   Blazquez A B ^a   Martin Acebes M A ^a,c   de Oya, N Jiménez ^a,d   Gutierrez Guzman A V ^b   Escribano, José M ^a   Hofle U ^b   Saiz, J C ^a  

^a INIA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d Laboratory of Tumor Immunology   (Italy)

Author keywords

Birds; Protection; Shedding; Transmission; Vaccine; West Nile virus

Indexed keywords

UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS RNA; WEST NILE VIRUS ANTIBODY;

ALECTORIS RUFA; ARTICLE; CONTROLLED STUDY; FEATHER; IMMUNIZATION; NONHUMAN; PARTRIDGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE; VIREMIA; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS SHEDDING; WEST NILE FLAVIVIRUS; WEST NILE FLAVIVIRUS INFECTION;

BIRDS; PROTECTION; SHEDDING; TRANSMISSION; VACCINE; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; BIRD DISEASES; BLOOD; CLOACA; GALLIFORMES; INJECTIONS, INTRAMUSCULAR; OROPHARYNX; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 84883601036     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.071     Document Type: Article

References (37)

1. Martín-Acebes M.A., Saiz J.C. West Nile virus: a re-emerging pathogen revisited. World Journal of Virology 2012, 1(2):51-70.
2. Centers for Disease Control and Prevention (CDC). ; 2013 [accessed 18.04.13]. http://www.cdc.gov/ncidod/dvbid/westnile/.
3. Komar N. West Nile virus: epidemiology and ecology in North America. Advances in Virus Research 2003, 61:185-234.
4. Dauphin G., Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007, 25(30):5563-5576.
5. Zohrabian A., Hayes E.B., Petersen L.R. Cost-effectiveness of West Nile virus vaccination. Emerging Infectious Diseases 2006, 12(3):375-380.
6. Diamond M.S. Virus and host determinants of West Nile virus pathogenesis. PLoS Pathogens 2009, 5(6):e1000452.
7. Turell M.J., Bunning M., Ludwig G.V., Ortman B., Chang J., Speaker T., et al. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Emerging Infectious Diseases 2003, 9(9):1077-1081.
8. Kilpatrick A.M., Dupuis A.P., Chang G.J., Kramer L.D. DNA vaccination of American robins (Turdus migratorius) against West Nile Virus. Vector-Borne and Zoonotic Diseases 2010, 10(4):377-380.
9. Redig P.T., Tully T.N., Ritchie B.W., Roy A.F., Baudena M.A., Chang G.J. Effect of West Nile virus DNA-plasmid vaccination on response to live virus challenge in red-tailed hawks (Buteo jamaicensis). American Journal of Veterinary Research 2011, 72(8):1065-1070.
10. Wheeler S.S., Langevin S., Woods L., Carroll B.D., Vickers W., Morrison S.A., et al. Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: implications for vaccination of Island Scrub-Jays (Aphelocoma insularis). Vector-Borne and Zoonotic Diseases 2011, 11(8):1069-1080.
11. Nusbaum K.E., Wright J.C., Johnston W.B., Allison A.B., Hilton C.D., Staggs L.A., et al. Absence of humoral response in flamingos and red-tailed hawks to experimental vaccination with a killed West Nile virus vaccine. Avian Diseases 2003, 47(3):750-752.
12. Chang G.J., Davis B.S., Stringfield C., Lutz C. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection. Vaccine 2007, 25(12):2325-2330.
13. Olsen G.H., Miller K.J., Docherty D.E., Bochsler V.S., Sileo L. Pathogenicity of West Nile virus and response to vaccination in sandhill cranes (Grus canadensis) using a killed vaccine. Journal of Zoo and Wildlife Medicine 2009, 40(2):263-271.
14. Aebischer N.J., Potts G.R. Red-legged partridge (Alectoris rufa). Birds in Europe: their conservation status. 1994, Birdlife International, Cambridge, UK. G.M. Tucker, M.F. Heath (Eds.).
15. Blanco-Aguiar J.A., Virgós E., Villafuente R. Perdiz roja (Alectoris rufa). Atlas de las aves reproductoras de España 2003, 212-213. Dirección General de Conservación de la Naturaleza y Sociedad Española de Ornitología, Madrid, Spain. R. Martí, J.C. del Moral (Eds.).
16. Wünschmann A., Ziegler A. West Nile virus-associated mortality events in domestic Chukar partridges (Alectoris chukar) and domestic Impeyan pheasants (Lophophorus impeyanus). Avian Diseases 2006, 50(3):456-459.
17. Sotelo E., Gutierrez-Guzmán A.V., Del Amo J., Llorente F., El-Harrak M., Pérez-Ramírez E., et al. Pathogenicity of two recent Western Mediterranean West Nile virus isolates in a wild bird species indigenous to Southern Europe: the red-legged partridge. Veterinary Research 2011, 42(1):11.
18. Alonso-Padilla J., Jiménez de Oya N., Blázquez A.B., Loza-Rubio E., Escribano J.M., Saiz J.C., et al. Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae. Journal of Virological Methods 2010, 166(1-2):37-41.
19. Alonso-Padilla J., De Oya N.J., Blázquez A.B., Escribano-Romero E., Escribano J.M., Saiz J.C. Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease. Vaccine 2011, 29(9):1830-1835.
20. Córdoba L., Escribano-Romero E., Garmendia A., Saiz J.C. Pregnancy increases the risk of mortality in West Nile virus-infected mice. Journal of General Virology 2007, 88(Pt2):476-480.
21. Martín-Acebes M.A., Saiz J.C. A West Nile virus mutant with increased resistance to acid-induced inactivation. Journal of General Virology 2011, 92(Pt 4):831-840.
22. Martín-Acebes M.A., Blázquez A.B., Jimenez de Oya N., Escribano-Romero E., Saiz J.C. West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids. PLoS ONE 2011, 6(9):e24970.
23. Alonso-Padilla J., Loza-Rubio E., Escribano-Romero E., Córdoba L., Cuevas S., Mejía F., et al. The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses. Epidemiology and Infection 2009, 137(8):1163-1168.
24. Rodríguez-Pulido M., Martín-Acebes M.A., Escribano-Romero E., Blázquez A.B., Sobrino F., Borrego B., et al. Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. PLoS ONE 2012, 7(11):e49494.
25. Lanciotti R.S., Kerst A.J., Nasci R.S., Godsey M.S., Mitchell C.J., Savage H.M., et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. Journal of Clinical Microbiology 2000, 38(11):4066-4071.
26. Blázquez A.B., Sáiz J.C. West Nile virus (WNV) transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion. Virus Research 2010, 151(2):240-243.
27. Bunning M.L., Fox P.E., Bowen R.A., Komar N., Chang G.J., Speaker T.J., et al. DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus. Avian Diseases 2007, 51(2):573-577.
28. Samina I., Havenga M., Koudstaal W., Khinich Y., Koldijk M., Malkinson M., et al. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine. Vaccine 2007, 25(49):8338-8345.
29. Jarvi S.I., Lieberman M.M., Hofmeister E., Nerurkar V.R., Wong T., Weeks-Levy C. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser). Vaccine 2008, 26(42):5338-5344.
30. Fassbinder-Orth C.A., Hofmeister E.K., Weeks-Levy C., Karasov W.H. Oral and parenteral immunization of chickens (Gallus gallus) against West Nile virus with recombinant envelope protein. Avian Diseases 2009, 53(4):502-509.
31. Silva M.S., Ellis A., Karaca K., Minke J., Nordgren R., Wu S., et al. Domestic goose as a model for West Nile virus vaccine efficacy. Vaccine 2013, 31:1045-1050.
32. Sotelo E., Fernandez-Pinero J., Llorente F., Agüero M., Hoefle U., Blanco J.M., et al. Characterization of West Nile virus isolates from Spain: new insights into distinct West Nile virus eco-epidemiology in the Western Mediterranean. Virology 2009, 395(2):289-297.
33. Naugle D.E., Aldridge C.L., Walker B.L., Cornish T.E., Moynahan B.J., Holloran M.J., et al. West Nile virus: pending crisis for greater sage-grouse. Ecology Letters 2004, 7:704-713.
34. Steele K.E., Linn M.J., Schoepp R.J., Komar N., Geisbert T.W., Manduca R.M., et al. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Veterinary Pathology 2000, 37(3):208-224.
35. Swayne D.E., Beck J.R., Smith C.S., Shieh W.J., Zaki S.R. Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerging Infectious Diseases 2001, 7(4):751-753.
36. Kilpatrick A.M., LaDeau S.L., Marra P.P. Ecology of West Nile virus transmission and its impact on birds in the western hemisphere. Auk 2007, 124:1121-1136.
37. Banet-Noach C., Simanov L., Malkinson M. Direct (non-vector) transmission of West Nile virus in geese. Avian Pathology 2003, 32(5):489-494.